Applied UV Granted Patents for Device Sterilizing ATM Surfaces
July 12 2022 - 7:00AM
Business Wire
Disinfects ATM Keyboard, Touchscreen and
Credit Card Reader Between Uses
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announces that its wholly owned subsidiary SteriLumen has been
notified that the US Patent and Trademark Office (USPTO) has
granted the patent pertaining to a system to neutralize pathogens
on ATM surfaces.
On a daily basis, consumers globally interact with numerous
surfaces that need to be touched during normal uses, including ATMs
with keyboards and interactive touch screens. As an example,
according to the Company’s internal research, as of 2018, there
were approximately 470,000 ATMs in the U.S. alone. These
surfaces are touched daily by an inordinate number of people that
can harbor and transfer pathogens highly associated with illnesses
and diseases. E.coli, salmonella and Staphylococcus aureus can be
found on these commonly used surfaces and can easily spread to
those in the general public if untreated; these bacteria and
viruses can be transferred easily to cause serious illness. Banks
are reducing the threat of litigation risk by incorporating the use
of the best science available to protect consumers from contracting
serious illnesses due to deadly surface pathogens found on
ATMs.
John F. Andrews, Applied UV’s CEO and Director, stated, “Our
global disinfection leadership position is further strengthened
with the issuance of this UVC Surface Pathogen Elimination Patent.
This patent grant further strengthens our SteriLumen disinfection
capabilities and applications to other business sectors that need
to safely and efficiently address the ever-increasing problem posed
by pathogens on surfaces in public spaces. Our pathogen
disinfection portfolio is a valuable piece of intellectual capital
designed to build shareholder value. The SterilLumen family of
proven disinfection technologies is very well positioned to help
businesses globally protect their facilities, employees, and
consumers from harmful airborne and surface related pathogens.”
Follow us on Twitter Follow us on LinkedIn
About Applied UV Applied UV is focused on the development
and acquisition of technology that address infection control in the
healthcare, hospitality, commercial and municipal markets. The
Company has two wholly owned subsidiaries - SteriLumen, Inc.
(“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s
connected platform for Data Driven Disinfection™ applies the power
of ultraviolet light (UVC) to destroy pathogens safely, thoroughly,
and automatically, addressing the challenge of healthcare-acquired
infections ("HAIs"). Targeted for use in facilities that have high
customer turnover such as hospitals, hotels, commercial facilities,
and other public spaces, the Company’s Lumicide™ platform uses UVC
LEDs in several patented designs for infection control in and
around high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following website:
https://www.applieduvinc.com/
Forward-Looking Statements The information contained
herein may contain “forward‐looking statements.” Forward-looking
statements reflect the current view about future events. When used
in this press release, the words “anticipate,” “believe,”
“estimate,” “expect,” “future,” “intend,” “plan,” or the negative
of these terms and similar expressions, as they relate to us or our
management, identify forward-looking statements. Such statements
include, but are not limited to, statements contained in this press
release relating to the view of management of Applied UV concerning
its business strategy, future operating results and liquidity and
capital resources outlook. Forward-looking statements are based on
the Company’s current expectations and assumptions regarding its
business, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict. The Company’s actual results may differ
materially from those contemplated by the forward-looking
statements. They are neither statements of historical fact nor
guarantees of assurance of future performance. We caution you
therefore against relying on any of these forward-looking
statements. Factors or events that could cause the Company’s actual
results to differ may emerge from time to time, and it is not
possible for the Company to predict all of them. The Company cannot
guarantee future results, levels of activity, performance, or
achievements. Except as required by applicable law, including the
securities laws of the United States, the Company does not intend
to update any of the forward-looking statements to conform these
statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220712005410/en/
For additional Company Information: Applied UV Inc. John F.
Andrews Applied UV CEO, Director john.andrews@applieduvinc.com
Brett Maas, Managing Principal Hayden IR brett@haydenir.com (646)
536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Apr 2024 to May 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From May 2023 to May 2024